• SENSEX 78,094.64
    166.49 (+0.21%)
  • BANKNIFTY 57,264.85
    117.35 (+0.21%)
  • Bajaj Finance
    1,151.20 1,151.20(%)
  • Torrent Pharma.
    5,139.30 5,139.30(%)
  • Netweb Technol.
    4,597.95 5,241.65(%)
  • TVS Motor Co.
    4,320.00 4,320.00(%)
  • Rossell Techsys
    979.95 1,111.00(%)
  • Indo-MIM
    815.90 815.90(%)
  • Kaynes Tech
    3,860.55 7,705.00(%)
  • Hero Motocorp
    5,397.80 6,390.00(%)
  • 63 Moons Tech.
    949.65 1,029.35(%)
  • Adani Ports
    1,707.00 1,891.80(%)
  • Shadowfax Technologies
    253.35 253.35(%)
  • Kalyan Jewellers
    610.15 327.15(%)
  • M & M
    3,456.00 3,840.00(%)
  • Tata Motors
    440.40 508.95(%)
  • HFCL
    194.30 229.40(%)
  • Hyundai Motor I
    2,208.90 2,889.65(%)
  • Swiggy
    280.00 235.85(%)
  • TBO Tek
    1,565.80 1,764.00(%)
  • Reliance Industries
    1,309.30 1,611.20(%)
  • Eicher Motors
    7,795.00 5,390.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sakar Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 66415.0
  • ISIN : INE732S01012
885.25 41 (4.84%)
  • As on 01 Aug 2026 (EOD)

  • Today’s Low

    845.05

  • Today’s High

    911.05

  • Open

    850.20

  • Perv Close

    844.40

  • 52W Low

    311.00

  • 52W High

    960.00

Key Indicators

  • P/E(TTM)

    54.58

  • Mar.Cap (₹Cr.)

    1,969.67

  • Div & Yield %

    0.00

  • Book Value(₹)

    145.86

  • Debt-Equity Ratio

    4.84

  • AGM Date

    31-Jul-2026

  • EPS

    16.22

  • P/E Ratio

    54.58

Financials Ratios

  • Debt-Equity Ratio

    0.46

  • Mar.Cap (₹Cr.)

    1,969.67

  • RONW (%)

    5.36

  • ROCE (%)

    7.36

Score Board

  • Equity (₹ in Cr.)

    22.25

  • BV (₹)

    145.90

  • Sales( ₹ in Cr.)

    251.74

  • NP (in Cr.)

    30.48

  • NP Var(%)

    72.0

  • Div%

    0.0

  • CPS (₹)

    24.30

  • EPS (₹)

    13.70

  • Traded Value (₹ in Lakhs)

    1,969.67

  • 52 Week High

    960.00

  • 52 Week Low

    311.00

  • Price BSE

    0.0

  • Price NSE

    885.00

  • Market Capital( in Cr.)

    1,969.67

  • P/C Ratio

    36.40

  • P/E Ratio

    64.60

  • Price Vs.BV

    13.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 177.58 153.35 133.36 128.23 94.74 82.98
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 177.58 153.35 133.36 128.23 94.74 82.98
Other Income 1.31 3.18 4.67 2.17 1.18 2.02
Stock Adjustments 13.20 1.38 0.36 -0.93 0.91 -0.15
Total Income 192.09 157.91 138.39 129.47 96.83 84.85
EXPENDITURE :            
Raw Materials 95.47 85.05 74.00 73.69 52.20 43.00
Power and Fuel Cost 5.15 4.25 2.90 3.01 2.26 3.31
Employee Cost 30.15 18.82 15.81 14.26 12.74 11.61
Other Manufacturing Expenses 0.36 0.74 0.69 0.95 0.90 0.89
Selling and Administration Expenses 8.91 6.92 6.85 5.70 4.11 4.38
Miscellaneous Expenses 1.12 0.57 0.34 0.28 0.84 0.09
Employee Benefit Expenses 30.15 18.82 15.81 14.26 12.74 11.61
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 141.16 116.36 100.58 97.89 73.04 63.28
Operating Profit 50.95 41.54 37.81 31.58 23.78 21.57
Interest 8.54 7.59 5.95 2.90 2.48 2.26
Gross Profit 42.41 33.95 31.86 28.68 21.30 19.31
Depreciation 20.88 18.05 14.99 9.67 8.06 7.08
Profit Before Tax 21.53 15.90 16.87 19.01 13.24 12.23
Current Tax 0.00 0.00 0.00 3.41 3.18 2.63
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.03 4.23 4.12 0.35 -0.63 -0.03
Reported Net Profit 17.50 11.67 12.76 15.24 10.69 9.62
Extraordinary Items -0.25 0.17 0.07 0.03 -0.11 -0.04
Adjusted Net Profit 17.75 11.50 12.69 15.21 10.80 9.66
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -0.75 0.00
P & L Balance brought forward 80.62 68.95 56.19 40.95 31.00 21.38
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 98.12 80.62 68.95 56.19 40.95 31.00
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.97 5.37 6.70 8.90 6.85 6.43
Earnings Per Share(Adj)-Unit Curr 7.97 5.37 6.70 8.90 6.85 6.43
Book Value 128.78 118.44 91.09 74.50 63.04 54.35
Book Value(Adj)-Unit Curr 128.78 118.44 91.09 74.50 63.04 54.35

Shareholding Pattern

  • Promoter Group

    52.52%

  • Public Share Holding

    47.48%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,685,043 52.52 11,685,043 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,685,043 52.52 11,685,043 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,700,018 12.13 2,700,018 10
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,529,958 11.37 2,529,958 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,229,976 23.51 5,229,976 17
2] Non Institution
Bodies Corporate 468,885 2.11 468,885 101
Clearing Members 9,489 0.04 9,489 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 203,587 0.92 203,587 327
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 172,562 0.78 172,562 305
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 866,723 3.90 866,723 19
Individuals holding nominal share capital up to Rs. 1 lakh 3,573,971 16.06 3,573,971 13,931
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2 0.00 2 1
Sub Total 5,334,891 23.98 5,334,891 14,713
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 22,249,910 100.00 22,249,910 14,734

Company Background

Sakar Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sakar Healthcare Ltd
  • BSE Code : 66415.0
  • ISIN : INE732S01012

  • Incorporation Year

    2004

  • Registered Office

    10/13 Nr MN Desai Petrol Pump
    Sarkhej Bavla Highway, Changodar,
    Gujarat-382213

  • Telephone

    91-2717-250477

  • FAX

    91-2717-251621

  • Chairman

    Sanjay S Shah.

  • Managing Director

    Sanjay S Shah.

  • Company Secretary

    Bharat Soni

  • Auditor

    J S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Sakar Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sakar Healthcare 885.25 178.90 177.58 54.58 8.37
Abbott India 27,784.15 7,217.19 6,929.05 38.04 43.78
Astrazeneca Phar 8,103.65 2,304.07 2,275.58 108.03 27.86
P & G Health Ltd 6,597.45 944.52 934.17 33.50 71.75
Glaxosmi. Pharma 2,653.45 3,932.76 3,790.20 44.42 58.17
Cipla 1,472.95 20,102.60 18,979.95 38.71 13.88
Amrutanjan Healt 515.00 469.50 451.82 25.71 21.89
Fermenta Biotec. 501.25 474.15 450.25 22.95 18.77
Bliss GVS Pharma 467.40 773.53 729.81 51.25 12.51
Guj. Themis Bio. 358.85 152.47 150.80 83.84 27.21
Ambalal Sarabhai 34.87 19.52 3.94 24.38 6.77